HemoSonics' Quantra® Hemostasis System

Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot

Dr. Jonathan Sadeh, ex-SVP of Immunology R&D at Bristol-Myers Squibb, joins Scinai Immunotherapeutics' Scientific Advisory Board

BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog®

Vaxxas begins a Phase I clinical trial for an H7N9 influenza vaccine using its high-density microarray patch (HD-MAP)

Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time

UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP

Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation

Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.

nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.

Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research

FDA approves Bristol Myers Squibb's COBENFY™, a novel treatment for adult schizophrenia.

Featured Press Releases

Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research

Jade Biosciences launches with $80 million to develop transformative autoimmune disease therapies

01 Aug 2024

Jade Biosciences, Inc. a biotechnology company dedicated to developing best-in-class therapies for...

Aadi Bioscience reports Q3 2024 financial results and updates on corporate progress

Children’s Hospital Los Angeles completes its 100th retinal gene therapy procedure, advancing pediatric vision care.

Nona Biosciences Updates on ADC Collaboration with BeiGene and DualityBio

Cognito Therapeutics Presents Spectris™ Data on Brain Structural Maintenance in Alzheimer’s at AD/PD™ 2025

Glenmark Pharmaceuticals Launches Vancomycin Hydrochloride for Injection in the U.S

By Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd
03 Apr 2025

IRBM Expands Functional Genomics Platform for Early Drug Discovery

By IRBM
IRBM
03 Apr 2025

Cognito Therapeutics Presents Spectris™ Data on Brain Structural Maintenance in Alzheimer’s at AD/PD™ 2025

By Cognito Therapeutics
Cognito Therapeutics
02 Apr 2025

PeptiGrowth Inc. Launches Novel Synthetic KGF Alternative Peptide (FGFR2b Agonist)

By PeptiGrowth Inc.
PeptiGrowth Inc.
02 Apr 2025

Hanmi Pharmaceutical Launches 'Aditams' in Mexico, Expanding into Latin America

By Hanmi Pharmaceutical
Hanmi Pharmaceutical
02 Apr 2025

ELIQUENT Life Sciences Acquires Truliant Consulting, Expanding Pharmacovigilance Platform

By ELIQUENT Life Sciences
ELIQUENT Life Sciences
01 Apr 2025

12th Annual PANAGORA Pharma CX Summit 2025

Most Popular

BioMarin to Present Data Showcasing VOXZOGO® (vosoritide)'s Impact on Bone Health and Quality of Life in Achondroplasia

By BioMarin Pharmaceutical Inc.

Jun 17
GoodRx debuts a new e-commerce platform, starting with Opill®

By GoodRx

Oct 31
NLS Pharmaceutics and Kadimastem announce a $500,000 initial closing of a $1 million fundraising, with shares priced at $3.10, a 48% premium over the January 6, 2025 market price

By Kadimastem Ltd.; NLS Pharmaceutics Ltd.

Jan 08

April 2025

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Search your requirement

Social media

HemoSonics' Quantra® Hemostasis System

Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot

Dr. Jonathan Sadeh, ex-SVP of Immunology R&D at Bristol-Myers Squibb, joins Scinai Immunotherapeutics' Scientific Advisory Board

BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog®

Vaxxas begins a Phase I clinical trial for an H7N9 influenza vaccine using its high-density microarray patch (HD-MAP)

Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time

UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP

Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation

Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.

nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.

Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research

FDA approves Bristol Myers Squibb's COBENFY™, a novel treatment for adult schizophrenia.

Featured Press Releases

Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research

Jade Biosciences launches with $80 million to develop transformative autoimmune disease therapies

Aadi Bioscience reports Q3 2024 financial results and updates on corporate progress

Children’s Hospital Los Angeles completes its 100th retinal gene therapy procedure, advancing pediatric vision care.

Nona Biosciences Updates on ADC Collaboration with BeiGene and DualityBio

Cognito Therapeutics Presents Spectris™ Data on Brain Structural Maintenance in Alzheimer’s at AD/PD™ 2025

Glenmark Pharmaceuticals Launches Vancomycin Hydrochloride for Injection in the U.S

IRBM Expands Functional Genomics Platform for Early Drug Discovery

Cognito Therapeutics Presents Spectris™ Data on Brain Structural Maintenance in Alzheimer’s at AD/PD™ 2025

PeptiGrowth Inc. Launches Novel Synthetic KGF Alternative Peptide (FGFR2b Agonist)

Hanmi Pharmaceutical Launches 'Aditams' in Mexico, Expanding into Latin America

ELIQUENT Life Sciences Acquires Truliant Consulting, Expanding Pharmacovigilance Platform

Most Popular

BioMarin to Present Data Showcasing VOXZOGO® (vosoritide)'s Impact on Bone Health and Quality of Life in Achondroplasia

GoodRx debuts a new e-commerce platform, starting with Opill®

NLS Pharmaceutics and Kadimastem announce a $500,000 initial closing of a $1 million fundraising, with shares priced at $3.10, a 48% premium over the January 6, 2025 market price

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe for e-Newsletter Monthly